Summit Securities Group’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-72,400
| Closed | -$50K | – | 470 |
|
|
2020
Q4 | $50K | Sell |
72,400
-57,000
| -44% | -$39.4K | ﹤0.01% | 251 |
|
|
2020
Q3 | $291K | Buy |
129,400
+18,000
| +16% | +$40.5K | 0.03% | 116 |
|
|
2020
Q2 | $399K | Sell |
111,400
-52,100
| -32% | -$187K | 0.05% | 83 |
|
|
2020
Q1 | $621K | Buy |
163,500
+20,300
| +14% | +$77.1K | 0.11% | 53 |
|
|
2019
Q4 | $431K | Buy |
+143,200
| New | +$431K | 0.03% | 143 |
|